HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,590
+40 (0.26%)
Oct 30, 2025, 3:30 PM KST
0.26%
Market Cap218.92B
Revenue (ttm)36.10B
Net Income (ttm)472.66M
Shares Out14.04M
EPS (ttm)34.13
PE Ratio463.17
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume266,392
Average Volume143,461
Open15,530
Previous Close15,550
Day's Range15,390 - 16,380
52-Week Range12,500 - 33,250
Beta0.37
RSI65.54
Earnings DateNov 13, 2025

About HLB Pharmaceutical

HLB Pharmaceutical Co., Ltd., a pharmaceutical company, researches and develops peptide drugs in South Korea. The company offers skeletal muscle relaxants, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthetics, antiarteriosclerotic agents, expectorants, antipyretics, analgesics, antidiabetic drug, chemotherapeutics, peptic ulcer agents, central nervous system drug, antibiotics, digestives, antacids, dent... [Read more]

Sector Healthcare
Founded 1998
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 047920
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.